|
2025
|
Invention
|
Formulations of a hepcidin peptide analogue. The present disclosure encompasses pharmaceutical co... |
|
|
Invention
|
Conjugated hepcidin mimetics.
The present invention provides hepcidin analogues with improved in... |
|
2024
|
Invention
|
Human interleukin (il)-17 cytokine binding peptides. The present disclosure provides peptide comp... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases.
The ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and aut... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
oncological, hematological, inflammatory and au... |
|
|
Invention
|
Compositions of peptide inhibitors of interleukin-23 receptor.
The present invention relates to ... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor. The present disclosure relates to peptide inhibito... |
|
2023
|
Invention
|
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel dise... |
|
|
Invention
|
A4b7 thioether peptide dimer antagonists.
The invention relates to thioether monomer and dimer p... |
|
|
Invention
|
Lipidated peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel ... |
|
|
Invention
|
Hepcidin analogues and uses thereof. The present invention relates, inter alia, to certain hepcid... |
|
|
Invention
|
Conjugated hepcidin mimetics. The present invention provides hepcidin analogues with improved in ... |
|
|
Invention
|
Hepcidin mimetics for treatment of sickle cell disease.
The disclosure provides compositions and... |
|
|
Invention
|
Combination therapy for treatment of iron overload diseases. The disclosure provides methods for ... |
|
|
Invention
|
Hepcidin mimetics for treatment of sickle cell disease. The disclosure provides compositions and ... |
|
|
P/S
|
Pharmaceuticals; pharmaceuticals for use in the treatment of cancer and blood diseases and disord... |
|
|
P/S
|
Pharmaceuticals; pharmaceuticals for use in the treatment of
cancer and blood diseases and disor... |
|
|
Invention
|
Methods for treating inflammatory bowel diseases with a4b7 integrin antagonists.
The disclosure ... |
|
|
P/S
|
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutic... |
|
|
P/S
|
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders Medical resea... |
|
|
Invention
|
Conjugated hepcidin mimetics.
Disclosed herein are peptides or hepcidin analogues with improved ... |
|
|
Invention
|
Conjugated hepcidin mimetics. Disclosed herein are peptides or hepcidin analogues with improved i... |
|
|
Invention
|
Conjugated hepcidin mimetics. The present invention provides peptides, which are hepcidin analogu... |
|
2022
|
Invention
|
Peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel cyclic pep... |
|
|
Invention
|
Bicyclic peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel b... |
|
|
Invention
|
Bicyclic peptide inhibitors of interleukin-23 receptor. The present invention relates to novel bi... |
|
|
Invention
|
Lipidated peptide inhibitors of interleukin-23 receptor. The present invention relates to novel l... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor. The present invention relates to novel cyclic pept... |
|
|
Invention
|
Hepcidin mimetics for treatment of hereditary hemochromatosis.
The disclosure provides methods f... |
|
|
Invention
|
Hepcidin mimetics for treatment of hereditary hemochromatosis. The disclosure provides methods fo... |
|
|
Invention
|
Conjugated hepcidin mimetics.
The present invention generally relates to peptide analogues, incl... |
|
|
Invention
|
Conjugated hepcidin mimetics.
The present invention relates, inter alia, to certain hepcidin pep... |
|
|
Invention
|
Conjugated hepcidin mimetics. The present invention generally relates to peptide analogues, inclu... |
|
|
Invention
|
Conjugated hepcidin mimetics. The present invention relates, inter alia, to certain hepcidin pept... |
|
2021
|
Invention
|
Compositions of peptide inhibitors of interleukin-23 receptor. The present invention relates to c... |
|
|
Invention
|
Novel a4b7 peptide monomer and dimer antagonists.
The invention relates to peptide dimer compoun... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. The p... |
|
|
Invention
|
Methods for treating inflammatory bowel diseases with alpha4beta7 integrin antagonists.
The inve... |
|
2020
|
Invention
|
Conjugated hepcidin mimetics.
The present invention provides hepcidin analogues, and related pha... |
|
|
Invention
|
Methods for synthesizing beta-homoamino acids.
Methods of making β-homoamino acids as intermedia... |
|
2019
|
P/S
|
SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTA... |
